HeartWare acquires CircuLite for $30 Million

| Printer friendly version

HeartWare International announced in a press release earlier this week that they acquired CircuLite, Inc. for $30 million, as well as possible additional payments up to $320 million subject to regulatory and commercial milestones.

According to its website, CircuLite has developed the CE Mark-approved SYNERGY miniature ventricular support system, a minimally invasive implant for the treatment of refractory chronic congestive heart failure. CircuLite describes the system as comprised of a micro-pump, inflow cannula and outflow graft, a percutaneous lead connected to a wearable external controller, and a lightweight, rechargeable dual battery back system implantable via a mini-thoracotomy incision.

Publicly-traded HeartWare has, according to its website, receivedĀ FDA PMA approval for its HEARTWARE Ventricular Assist System for use as a bridge to cardiac transplantation in patients at risk of death from refractory congestive heart failure.



Bryan Wahl
Bryan W. Wahl is a partner in our Orange County office. He specializes in intellectual property protection, infringement studies, financings, and strategic transactions especially with respect to medical devices and biotechnology.
Click here to read full bio
View all posts published by Bryan Wahl »

Leave a Reply

By using this blog, you agree and understand that no information is being provided in the context of any attorney-client relationship. You further agree and understand that nothing herein is intended to be legal advice. This blog is solely informational in nature, and is not intended as, and should not be used as, a substitute for competent legal advice from a retained and licensed attorney in your state. Knobbe Martens LLP makes no representations or warranties as to the accuracy, completeness, timeliness or availability of the information in this blog. Knobbe Martens LLP will not be liable for any injury or damages relating to your use of, or access to, any such information. Knobbe Martens LLP undertakes no obligation to correct or update information on this blog, which may be incorrect or become incorrect or out of date over time. Knobbe Martens LLP reserves the right to alter or delete content or information on the blog at any time. This blog contains links and references to other websites and publications that you may find of interest. Knobbe Martens LLP does not control, promote, endorse or otherwise have any affiliation with any other websites or publications unless those websites or publications expressly state such an affiliation. Knobbe Martens LLP further has no responsibility for, and makes no representations regarding, the content, accuracy or any other aspect of the information in such websites or publications.